Measures of outcome in lung cancer screening: Maximising the benefits

Journal of Thoracic Disease

Volumn 8, Issue 10, 2016, Pages E1317-E1320

  Young, Robert Peter ^a   Hopkins, Raewyn Janice ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; SPIROMETRY; SURVIVAL RATE; THORAX RADIOGRAPHY;

EID: 84995527853     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2016.10.49     Document Type: Editorial

References (25)

1. Miller DL, Mayfield WR, Luu TD, et al. Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival. Ann Thorac Surg 2016;101:1864-9
2. Twombly R. Lung cancer screening debate continues despite international CT study results. J Natl Cancer Inst 2007;99:190-5
3. Welch HG, Woloshin S, Schwartz LM, et al. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 2007;167:2289-95
4. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71
5. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012;157:571-3
6. Ruano-Ravina A, Heleno B, Fernández-Villar A. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit. J Epidemiol Community Health 2015;69:99-100
7. Young RP, Duan F, Greco E, et al. Lung cancer-specific mortality reduction with CT screening: outcomes according to airflow limitation in the ACRIN NLST sub-study (N=18, 475). Am J Respir Crit Care Med 2016;193:A6166
8. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409
9. Patz EF Jr, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74
10. Midthun DE. Early detection of lung cancer. F1000Res 2016;5. pii: F1000 Faculty Rev-739. doi: 10.12688/f1000research.7313.1
11. Cui JW, Li W, Han FJ, et al. Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals. Transl Lung Cancer Res 2015;4:275-86
12. Pastorino U. Lung cancer screening. Br J Cancer 2010;102:1681-6
13. Chirieac LR, Flieder DB. High-resolution computed tomography screening for lung cancer: unexpected findings and new controversies regarding adenocarcinogenesis. Arch Pathol Lab Med 2010;134:41-8
14. Young RP, Duan F, Chiles C, et al. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med 2015;192:1060-7
15. Young RP, Hopkins RJ. Targeted CT image screening and its effect on lung cancer detection rate. Chest 2013;144:1419-20
16. Kondo R, Yoshida K, Kawakami S, et al. Efficacy of CT screening for lung cancer in never-smokers: analysis of Japanese cases detected using a low-dose CT screen. Lung Cancer 2011;74:426-32
17. Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e78S-92S
18. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lungcancer death. N Engl J Med 2013;369:245-54
19. Gray EP, Teare MD, Stevens J, et al. Risk Prediction Models for Lung Cancer: A Systematic Review. Clin Lung Cancer 2016;17:95-106
20. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007;30:616-22
21. Yip R, Henschke CI, Yankelevitz DF, et al. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. Eur J Cancer Prev 2015;24:201-8
22. Prasad V, Lenzer J, Newman DH. Why cancer screening has never been shown to "save lives"-and what we can do about it. BMJ 2016;352:h6080
23. Gigerenzer G. Full disclosure about cancer screening. BMJ 2016;352:h6967
24. Gould MK. Lung Cancer Screening in Individuals with Chronic Obstructive Pulmonary Disease. Finding the Sweet Spot. Am J Respir Crit Care Med 2015;192:1027-8
25. Ruano-Ravina A, Provencio-Pulla M, Fernández-Villar A. Lung cancer screening white paper: a slippery step forward? Eur Respir J 2015;46:1519-20